Literature DB >> 6829930

Effects of fentanyl, naloxone, and clonidine on hemodynamics and plasma catecholamine levels in dogs.

J W Flacke, W E Flacke, B C Bloor, S Olewine.   

Abstract

A 50-micrograms/kg dose of fentanyl, given intravenously in divided doses to dogs under enflurane-nitrous oxide anesthesia caused sharp decreases in heart rate (HR), arterial blood pressure (AP), left ventricular dP/dt, and plasma levels of catecholamines. Naloxone, 20 micrograms/kg given 65-70 min later, completely and rapidly reversed these changes. Because the cardiovascular effects of fentanyl and naloxone occurred in unparalyzed animals under surgical anesthesia without eliciting any motor responses, it seems unlikely that they can be ascribed to changes in awareness and surgical stimulation, especially pain. The brief duration of exposure to the narcotic makes it improbable that the naloxone response is due to acute dependence and precipitated withdrawal. Pretreatment with 20 micrograms/kg of atropine only attenuated the decrease in HR, indicating a minor role of vagal mechanisms under these conditions. Administration of 20 micrograms/kg of clonidine by slow infusion after fentanyl further reduced sympathetic activity and greatly attenuated the naloxone response. Injection of 5 mg/kg of tolazoline after administration of clonidine produced massive cardiovascular stimulation by antagonizing clonidine and unmasking the naloxone reversal of fentanyl. Thus, in fully anesthetized dogs, fentanyl decreased the level of cardiovascular function mainly by reducing sympathetic activity. This effect does not seem to be secondary to analgesia or other sensory depressant effects of the narcotic, but rather to an action on central opioid-sensitive mechanisms regulating cardiovascular function.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6829930

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  12 in total

1.  Power spectral analysis of heart rate variability during positive pressure pneumoperitoneum: the significance of increased cardiac sympathetic expression.

Authors:  A Bickel; M Yahalom; N Roguin; R Frankel; J Breslava; S Ivry; A Eitan
Journal:  Surg Endosc       Date:  2002-05-03       Impact factor: 4.584

2.  The cardiovascular effects of naloxone administration after fentanyl anesthesia in hypercapnic patients.

Authors:  Kazuhiro Kishikawa; Akiyoshi Namiki; Hiroshi Iwasaki
Journal:  J Anesth       Date:  1989-03-01       Impact factor: 2.078

3.  Comparison of the efficacy of three premedicants administered to cats.

Authors:  D H Dyson; P J Pascoe; V Honeyman; J E Rahn
Journal:  Can Vet J       Date:  1992-07       Impact factor: 1.008

4.  Inhibition by vecuronium of carbachol-induced influx of 22Na+, 45Ca2+ and secretion of catecholamines in cultured bovine adrenal medullary cells.

Authors:  A Wada; M Arita; H Takara; K Sumikawa; Y Uezono; F Izumi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

5.  Narcotic reversal in hypercapnic dogs: comparison of naloxone and nalbuphine.

Authors:  C A Mills; J W Flacke; W E Flacke; B C Bloor; M D Liu
Journal:  Can J Anaesth       Date:  1990-03       Impact factor: 5.063

6.  Neurohormonal and metabolic effects of medetomidine compared with xylazine in beagle dogs.

Authors:  T D Ambrisko; Y Hikasa
Journal:  Can J Vet Res       Date:  2002-01       Impact factor: 1.310

7.  Dexmedetomidine-induced decrease in cerebral blood flow is attenuated by verapamil in rats: a laser Doppler study.

Authors:  F Bari; G Horváth; G Benedek
Journal:  Can J Anaesth       Date:  1993-08       Impact factor: 5.063

8.  Haemodynamic effects of verapamil administration after large doses of fentanyl in man.

Authors:  P A Kapur; E J Norel; H Dajee; G Cohen; W Flacke
Journal:  Can Anaesth Soc J       Date:  1986-03

Review 9.  Adverse effects of opioid agonists and agonist-antagonists in anaesthesia.

Authors:  T A Bowdle
Journal:  Drug Saf       Date:  1998-09       Impact factor: 5.606

10.  Pharmacologic Modulation of Noxious Stimulus-evoked Brain Activation in Cynomolgus Macaques Observed with Functional Neuroimaging.

Authors:  Tomomi Shirai; Mizuho Yano; Takahiro Natsume; YūJi Awaga; Yoshitaka Itani; Aldric Hama; Akihisa Matsuda; Hiroyuki Takamatsu
Journal:  J Am Assoc Lab Anim Sci       Date:  2019-11-21       Impact factor: 1.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.